Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr;22(2):113-21.
doi: 10.3747/co.22.2300.

Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec

Affiliations

Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec

A L Smith et al. Curr Oncol. 2015 Apr.

Abstract

Background: Enrolling patients in studies of pancreatic ductal adenocarcinoma (pdac) is challenging because of the high fatality of the disease. We hypothesized that a prospective clinic-based study with rapid ascertainment would result in high participation rates. Using that strategy, we established the Quebec Pancreas Cancer Study (qpcs) to investigate the genetics and causes of pdac and other periampullary tumours (pats) that are also rare and underrepresented in research studies.

Methods: Patients diagnosed with pdac or pat were introduced to the study at their initial clinical encounter, with a strategy to enrol participants within 2 weeks of diagnosis. Patient self-referrals and referrals of unaffected individuals with an increased risk of pdac were also accepted. Family histories, epidemiologic and clinical data, and biospecimens were collected. Additional relatives were enrolled in families at increased genetic risk.

Results: The first 346 completed referrals led to 306 probands being enrolled, including 190 probands affected with pdac, who represent the population focus of the qpcs. Participation rates were 88.4% for all referrals and 89.2% for pdac referrals. Family history, epidemiologic and clinical data, and biospecimens were ascertained from 91.9%, 54.6%, and 97.5% respectively of patients with pdac. Although demographics and trends in risk factors in our patients were consistent with published statistics for patients with pdac, the qpcs is enriched for families with French-Canadian ancestry (37.4%), a population with recurrent germ-line mutations in hereditary diseases.

Conclusions: Using rapid ascertainment, a pdac and pat research registry with high participation rates can be established. The qpcs is a valuable research resource and its enrichment with patients of French-Canadian ancestry provides a unique opportunity for studies of heredity in these diseases.

Keywords: Pancreatic cancer; cancer genetics; periampullary tumours; research registry; translational research.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Ages at diagnosis (in years) and pancpro scores for all enrolled probands with a diagnosis of pancreatic ductal adenocarcinoma and an available pedigree (n = 175). Dashed lines indicate the mean age and the mean PancPRO score (ranges given in parentheses). pancpro model courtesy of BayesMendel Lab, Harvard University, Cambridge, MA, U.S.A.

Similar articles

Cited by

References

    1. Canadian Cancer Society’s Advisory Committee on Cancer Statistics . Canadian Cancer Statistics 2014. Toronto, ON: Canadian Cancer Society; 2014.
    1. Howlader N, Noone AM, Krapcho M, et al., editors. SEER Cancer Statistics Review, 1975–2011 [Web resource] Bethesda, MD: U.S. National Cancer Institute; 2013. [Downloadable from: http://seer.cancer.gov/csr/1975_2011; cited November 26, 2014]
    1. Hurton S, MacDonald F, Porter G, Walsh M, Molinari M. The current state of pancreatic cancer in Canada: incidence, mortality, and surgical therapy. Pancreas. 2014;43:879–85. doi: 10.1097/MPA.0000000000000147. - DOI - PubMed
    1. Hidalgo M. Pancreatic cancer. N Eng J Med. 2010;362:1605–17. doi: 10.1056/NEJMra0901557. [Erratum in: N Engl J Med 2010;363:298] - DOI - PubMed
    1. Wolfgang CL, Herman JM, Laheru DA, et al. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63:318–48. doi: 10.3322/caac.21190. - DOI - PMC - PubMed

LinkOut - more resources